← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2008Last known activity
Dec 15, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 7 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT05558280Lead sponsorPhase 2Dec 15, 2022
- NCT05558280Sponsor investigatorPhase 2Dec 15, 2022
- NCT04802070Sponsor investigatorPhase 1Jan 11, 2021
- NCT04802070Lead sponsorPhase 1Jan 11, 2021
- NCT03782363Overall official - principal investigatorPhase 1Mar 1, 2020
- NCT03782363CollaboratorPhase 1Mar 1, 2020
- NCT03918798Overall official - principal investigatorPhase 2Feb 14, 2019
- NCT01559012Reponsible party - principal investigatorPhase 3Feb 1, 2012
- NCT01592734CollaboratorPhase 4May 1, 2010
- NCT00893711Reponsible party - principal investigatorN/AMar 1, 2008
- NCT00893711Lead sponsorN/AMar 1, 2008
Details
- Last known activity
- Dec 15, 2022